🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 18 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/01/2009 8,50 9,20 8,40 8,70 +1,75% 9,41% 7.440
27/01/2009 9,20 9,20 8,50 8,55 +0,59% 7,61% 7.090
26/01/2009 11,00 11,00 8,50 8,50 -2,30% 22,73% 11.590
23/01/2009 9,30 9,30 8,50 8,70 -3,33% 8,60% 11.430
22/01/2009 9,20 9,50 8,70 9,00 +1,12% 8,70% 5.770
21/01/2009 9,40 9,40 8,40 8,90 -5,32% 10,64% 9.350
20/01/2009 9,30 9,70 9,00 9,40 +4,44% 7,53% 7.190
16/01/2009 9,60 10,00 8,80 9,00 -2,17% 12,50% 8.130
15/01/2009 10,20 10,20 9,20 9,20 -6,12% 9,80% 5.100
14/01/2009 10,00 10,40 9,60 9,80 +1,03% 8,00% 8.780
13/01/2009 10,70 10,70 9,70 9,70 -6,73% 9,35% 6.780
12/01/2009 11,70 11,80 10,30 10,40 -7,31% 12,82% 7.910
09/01/2009 11,80 11,80 11,10 11,22 -3,28% 5,93% 1.750
08/01/2009 12,10 12,10 11,20 11,60 -0,85% 7,44% 3.620
07/01/2009 12,40 12,40 11,40 11,70 -2,50% 8,06% 4.330
06/01/2009 11,80 12,30 11,00 12,00 +2,56% 11,02% 12.420
05/01/2009 10,80 11,70 10,50 11,70 +11,43% 11,11% 5.890
02/01/2009 9,50 11,00 9,20 10,50 +14,13% 18,95% 7.350
31/12/2008 9,20 9,80 9,00 9,20 -1,08% 8,70% 7.570
30/12/2008 9,50 9,52 9,00 9,30 -2,11% 5,47% 12.740
29/12/2008 10,00 10,10 9,50 9,50 -5,00% 6,00% 16.600
26/12/2008 9,90 10,40 9,90 10,00 -2,53% 5,05% 7.440
24/12/2008 10,20 10,50 9,90 10,26 +2,60% 5,88% 6.870
23/12/2008 12,00 12,50 10,00 10,00 -9,91% 20,83% 21.450
22/12/2008 11,60 12,15 11,00 11,10 -7,50% 9,91% 9.110
19/12/2008 11,40 13,30 11,40 12,00 -4,00% 16,67% 7.800
18/12/2008 14,00 14,00 12,50 12,50 -6,02% 10,71% 5.840
17/12/2008 13,70 13,70 13,20 13,30 -3,62% 3,65% 4.280
16/12/2008 14,00 14,50 13,00 13,80 -6,12% 10,71% 7.440
15/12/2008 13,10 14,70 13,00 14,70 +10,53% 12,98% 4.480